Therefore, to treat CIDA in patients with HHT, hemoglobin levels, serum ferritin and maybe soluble transferrin receptors, are important diagnostic markers and should be routinely measured [31]. The gene discussed is TFRC; the disease is hereditary hemorrhagic telangiectasia.